Google search engine

HomeUncategorizedPfizer yanks sickle-cell treatment worldwide after possible link to deaths

Pfizer yanks sickle-cell treatment worldwide after possible link to deaths

By launch-wire.com

25 September 2024

0

The benefits of Oxbryta no longer outweigh the risks, Pfizer says.

Previous article

Here’s who is considered middle class, as Harris and Trump fight for their votes

Next article

Dollar General asks shareholders to reject investment firm’s stock-purchase offer

RELATED ARTICLES

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

Most Popular

Recent Comments